<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1655579</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2025.1655579</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Pulsed electromagnetic fields preconditioned extracellular vesicles derived from mesenchymal stromal cells prevents necroptosis of osteoblasts in osteonecrosis of the femoral head rats</article-title>
<alt-title alt-title-type="left-running-head">Xiang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2025.1655579">10.3389/fbioe.2025.1655579</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xiang</surname>
<given-names>Xiao-Na</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3115741/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jiang-Yin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3221566/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiang-Xiu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3221597/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Hong-Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2293132/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>He</surname>
<given-names>Cheng-Qi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/597184/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Rehabilitation Sciences, West China School of Medicine, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/158891/overview">Martijn van Griensven</ext-link>, Maastricht University, Netherlands</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1569450/overview">Han Liu</ext-link>, Shanghai University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/870133/overview">Mohammad Karimipour</ext-link>, Tabriz University of Medical Sciences, Iran</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3125953/overview">Farah Daou</ext-link>, University of Eastern Piedmont, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Cheng-Qi He, <email>hxkfhcq2015@126.com</email>
</corresp>
<fn fn-type="other" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>ORCID: Xiao-Na Xiang, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0001-8659-1080">orcid.org/0000-0001-8659-1080</ext-link>; Cheng-Qi He, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-5349-0571">orcid.org/0000-0002-5349-0571</ext-link>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1655579</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Xiang, Zhang, Wang, He and He.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Xiang, Zhang, Wang, He and He</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Osteonecrosis of the femoral head (ONFH) is a refractory orthopedic disease in which steroids may induce bone cell necroptosis. Extracellular vesicles derived from bone marrow mesenchymal stromal cells (BMSC-EVs) are recognized as novel therapies to improve ONFH. Pulsed electromagnetic fields (PEMFs) increase the paracrine activity of BMSCs. Nonetheless, the effect and mechanism of PEMFs preconditioned BMSC-EVs (BMSC-EVs<sup>PEMFs</sup>) for treating ONFH are unclear.</p>
</sec>
<sec>
<title>Methods</title>
<p>The BMSC-EVs<sup>PEMFs</sup> with different magnetic amplitudes were incubated with dexamethasone-induced MC3T3-E1 cells and the osteogenic differentiation and necroptosis were observed. Furthermore, RNA sequencing of MC3T3-E1 cells incubated with incubated with PEMFs of a specific amplitude or without PEMFs was conducted to identify potential mechanisms involved. Reverse transcription&#x2012;quantitative polymerase chain reaction (RT-qPCR), immunofluorescence and Western blotting were performed to detect necroptosis-related pathways. SD rats receiving steroid injections were randomly assigned to receive PBS, BMSC-EVs or BMSC-EVs<sup>PEMFs</sup> therapy. Micro-CT scan, histological, and immunohistochemical analyses were used to evaluate the therapeutic effects on bone formation and necroptosis of the femoral head in ONFH animals.</p>
</sec>
<sec>
<title>Results</title>
<p>The characteristics of the BMSC-EVs<sup>PEMFs</sup> were similar to those of the BMSC-EVs. <italic>In vitro</italic>, co-culture of osteoblasts and PEMFs with 3&#xa0;millitesla (mT) amplitude preconditioned BMSC-EVs (BMSC-EVs<sup>PEMFs (3 mT)</sup> promoted osteogenic differentiation and inhibited cell death. The results of RNA sequencing revealed that the expression of Ripk3 was significantly lower in the BMSC-EVs<sup>PEMFs (3 mT)</sup> group than in the BMSC-EVs group. RT-qPCR, immunofluorescence and Western blotting revealed that the expression of necroptosis-related molecules (RIPK1, RIPK3, and MLKL) was suppressed in BMSC-EVs<sup>PEMFs (3 mT)</sup> group (<italic>p</italic> &#x3c; 0.05). <italic>In vivo</italic>, the BMSC-EVs<sup>PEMFs (3 mT)</sup> group presented better bone morphology of the femoral head via micro-CT, with a lower protein expression of MLKL and a higher expression of RUNX2 (<italic>p</italic> &#x3c; 0.05) at 2&#xa0;weeks, while lower expressions of RIPK1 and RIPK3, and higher levels of RUNX2 and OCN (<italic>p</italic> &#x3c; 0.05) at the femoral head at 6&#xa0;weeks after injection than did the BMSCs-EVs group.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>PEMFs with 3&#xa0;mT amplitude preconditioned BMSC-EVs could promote bone formation by inhibiting osteoblasts necroptosis via Ripk1&#x2013;Ripk3&#x2013;Mlkl signaling in ONFH.</p>
</sec>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<graphic xlink:href="FBIOE_fbioe-2025-1655579_wc_abs.tif">
<alt-text content-type="machine-generated">Illustration showing a study design involving rats and bone marrow stem cells (BMSCs) exposed to specific pulsed electromagnetic fields (PEMFs). Rats undergo treatment for glucocorticoid-induced osteonecrosis of the femoral head (ONFH). Observations occur at two and six weeks. A diagram depicts BMSC-extracellular vesicles reducing necroptosis in dexamethasone-induced osteoblasts, promoting osteogenesis and bone formation.</alt-text>
</graphic>
</fig>
</p>
</abstract>
<kwd-group>
<kwd>osteonecrosis of the femoral head</kwd>
<kwd>extracellular vesicles</kwd>
<kwd>bone marrow mesenchymalstromal cells</kwd>
<kwd>pulsed electromagnetic fields</kwd>
<kwd>necroptosis</kwd>
</kwd-group>
<counts>
<page-count count="17"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Tissue Engineering and Regenerative Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Glucocorticoids, although widely prescribed as anti-inflammatory and immunomodulatory agents, are a major cause of osteonecrosis of the femoral head (ONFH) due to their detrimental effects on bone metabolism (<xref ref-type="bibr" rid="B41">Padhye et al., 2016</xref>; <xref ref-type="bibr" rid="B39">Mimura et al., 2023</xref>). ONFH affects over 8 million individuals in China, with an average onset age of 58.3&#xa0;years (<xref ref-type="bibr" rid="B36">Mi crosurgery Department of the Orthopedics Branch of the Chinese Medical Doctor A et al., 2017</xref>; <xref ref-type="bibr" rid="B26">Lamb et al., 2019</xref>), and most individuals with ONFH suffer pain and collapse of the femoral head leading to subsequent deterioration of the hip joint (<xref ref-type="bibr" rid="B23">Kawano et al., 2020</xref>). Since patients are young, guidelines suggest the implementation of multiple techniques aimed at preserving hips (<xref ref-type="bibr" rid="B19">Hannon et al., 2023</xref>; <xref ref-type="bibr" rid="B63">Zhao et al., 2020</xref>), yet the optimal surgical approach remains debated (<xref ref-type="bibr" rid="B38">Miladi et al., 2018</xref>; <xref ref-type="bibr" rid="B43">Sadile et al., 2016</xref>; <xref ref-type="bibr" rid="B37">Migliorini et al., 2021</xref>). ONFH is characterized by the decrease in bone formation and situ death of bone cells, making it difficult for affected bones to recover (<xref ref-type="bibr" rid="B5">Chan et al., 2020</xref>). Numerous studies have reported that imbalanced programmed cell death, such as apoptosis (<xref ref-type="bibr" rid="B64">Zhao et al., 2023</xref>; <xref ref-type="bibr" rid="B6">Chen et al., 2020</xref>), necroptosis (<xref ref-type="bibr" rid="B13">Fan et al., 2022</xref>; <xref ref-type="bibr" rid="B15">Feng et al., 2023</xref>) and pyroptosis (<xref ref-type="bibr" rid="B14">Fang et al., 2024</xref>), disrupts bone homeostasis and causes osteonecrosis (<xref ref-type="bibr" rid="B44">Shao et al., 2024</xref>). Therefore, alternative approaches for preventing bone cell death and the progression of ONFH during the initial phase are urgently needed.</p>
<p>Bone marrow mesenchymal stromal cells (BMSCs) exhibit therapeutic effects for ONFH as their potential to promote osteogenesis and angiogenesis (<xref ref-type="bibr" rid="B10">Daltro et al., 2015</xref>). However, challenges such as limited progenitor cell availability, poor survival of transplanted cells, immune rejection, and possible pro-tumor risks restrict their clinical translation (<xref ref-type="bibr" rid="B35">McKinley et al., 2023</xref>). Extracellular vesicles (EVs), nanoscale mediators of intercellular communication, have recently attracted attention as cell-free alternatives (<xref ref-type="bibr" rid="B3">Boulestreau et al., 2021</xref>; <xref ref-type="bibr" rid="B34">Lu et al., 2022</xref>) and new tools for managing diseases (<xref ref-type="bibr" rid="B18">Han et al., 2024</xref>; <xref ref-type="bibr" rid="B53">Wang et al., 2025</xref>; <xref ref-type="bibr" rid="B33">Liu et al., 2024</xref>). BMSC-derived EVs (BMSC-EVs) have been shown to alleviate ONFH by enhancing cell survival (<xref ref-type="bibr" rid="B20">Huang et al., 2020</xref>), promoting osteoblast proliferation (<xref ref-type="bibr" rid="B32">Liao et al., 2019</xref>), and stimulating bone microvascular endothelial activity (<xref ref-type="bibr" rid="B28">Li L. et al., 2020</xref>). Due to the limited accessibility and poor yield of BMSC-EVs (<xref ref-type="bibr" rid="B11">Debbi et al., 2022</xref>; <xref ref-type="bibr" rid="B65">Zhou et al., 2024</xref>), it is crucial to enhance their specific biological functions.</p>
<p>Preconditioning strategies offer a potential solution. Pulsed electromagnetic fields (PEMFs) are known to regulate MSC proliferation, differentiation, and paracrine activity (<xref ref-type="bibr" rid="B4">Celik et al., 2021</xref>; <xref ref-type="bibr" rid="B42">Parate et al., 2020</xref>). Recent study indicated that PEMFs regulated the bioactivity of M2 macrophage-derived EVs on decreasing osteoclastogenesis (<xref ref-type="bibr" rid="B51">Trentini et al., 2024</xref>). Our previous work further showed that PEMF preconditioning enhances the anti-apoptotic effects of MSC-EVs, with 75&#xa0;Hz yielding the most pronounced benefits (<xref ref-type="bibr" rid="B58">Xu et al., 2022</xref>). Nevertheless, the optimal remain undefined, and the therapeutic efficacy and mechanisms of PEMFs preconditioned BMSC-EVs (BMSC-EVs<sup>PEMFs</sup>) in the ONFH animals are still unclear.</p>
<p>In the present study, we examined the effects of BMSC-EVs<sup>PEMFs</sup> on osteogenesis and necroptosis, offering an initial exploration of the mechanisms involved. Additionally, we explored the potential of BMSC-EVs<sup>PEMFs</sup> as an innovative biomimetic approach to enhance bone regeneration and reduce programmed cell death in a model of ONFH rats.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Isolation and identification of BMSCs</title>
<p>Three-week-old male Sprague-Dawley rats were humanely euthanized, and the femurs and tibias were harvested under sterile conditions. Culture method was previously reported (<xref ref-type="bibr" rid="B1">Aghaloo et al., 2010</xref>; <xref ref-type="bibr" rid="B56">Wu et al., 2024</xref>), and operation flow is shown in <xref ref-type="sec" rid="s13">Supplementary Figure S1</xref>. The cells from the third or fourth passage were used for the subsequent experiments.</p>
<p>The levels of cell surface markers, including CD44, CD34, CD45, and CD90, were analyzed following the guidelines provided by the manufacturer (<xref ref-type="bibr" rid="B45">Shi et al., 2014</xref>). Additionally, the capacity for multi-lineage differentiation was assessed by Alizarin red staining (ARS), Oil red O staining, and Alcian blue staining (Cyagen, China) after 7-day, 21-day, and 28-day stimulations. Colony-forming unit assays were initially performed with 1 &#xd7; 10<sup>3</sup> single-cell suspensions seeded in a 10&#xa0;cm diameter culture dish (Corning, United States), and reflected by toluidine blue (Beyotime, China) after 14&#xa0;days.</p>
</sec>
<sec id="s2-2">
<title>2.2 PEMFs intervention</title>
<p>The PEMFs device (School of Manufacturing Science and Engineering, Sichuan University, China) (<xref ref-type="bibr" rid="B22">Huang et al., 2022</xref>; <xref ref-type="bibr" rid="B52">Wang et al., 2022</xref>) consists of a pulse generator, a stepper motor driver, and a Helmholtz coil, and produces spatially homogeneous, time-varying magnetic fields in the incubator (seen in <xref ref-type="sec" rid="s13">Supplementary Figure S2</xref>; <xref ref-type="sec" rid="s13">Supplementary Table S1</xref>). There are two trays inside the circular Helmholtz coil chamber, and the output waveform from the signal generator produced a pulsed burst with a duty ratio of 50% (burst width: 6.67&#xa0;ms; pulse width: 6.67&#xa0;ms), repeated at a frequency of 75&#xa0;Hz. The magnetic flux density increased to a predetermined maximal level within approximately 50&#xa0;&#x3bc;s (with a rise rate of &#x223c;17&#xa0;T/s) when driving field amplitudes ranged between 0.5 and 3.8&#xa0;mT. This was measured using a hand-held Gaussmeter (HT201, Hengtong, China). According to previous studies, BMSCs at passage 4 hungered with 5% EVs-free FBS for 48&#xa0;h, and then were placed in the incubator under PEMFs with 0 (negative control), 1&#xa0;mT (<xref ref-type="bibr" rid="B4">Celik et al., 2021</xref>), 1.6&#xa0;mT (<xref ref-type="bibr" rid="B21">Huang et al., 2021</xref>; <xref ref-type="bibr" rid="B60">Yang et al., 2018</xref>), or 3&#xa0;mT (<xref ref-type="bibr" rid="B42">Parate et al., 2020</xref>) amplitudes for 60&#xa0;min.</p>
</sec>
<sec id="s2-3">
<title>2.3 EVs isolation, labeling, and uptake</title>
<p>BMSC-EVs were isolated via ultra-centrifugation method as previously described (<xref ref-type="bibr" rid="B17">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="B57">Xu et al., 2021</xref>) and flow is shown in <xref ref-type="sec" rid="s13">Supplementary Figure S3</xref>. The culture media were harvested, centrifuged at 300 &#xd7; <italic>g</italic> and 2,000 &#xd7; <italic>g</italic> to remove debris, and then filtered through a 0.22&#xa0;&#x3bc;m filter (Merck-Millipore). The supernatant was aliquoted into 15&#xa0;mL Amicon Ultra-15 devices with a 100&#xa0;kDa membrane and subjected to centrifugation at 4,000 &#xd7; <italic>g</italic>. Then, it was ultra-centrifuged at 100,000 &#xd7; <italic>g</italic> for 70&#xa0;min (SW32Ti, Beckman Coulter), washed with PBS, and ultra-centrifuged again at the same speed for 70&#xa0;min. The EVs were carefully resuspended in sterile PBS and stored at &#x2212;80&#xa0;&#xb0;C for subsequent experiments. Transmission electron microscopy (TEM) (JEM-1400FLASH, Japan) was used for observing morphology operating at 80&#x2013;120&#xa0;kV. For particle size and number analysis, nanoparticle trafficking analysis (NTA) was completed using the ZetaView system (Particle Metrix, Germany) following the manufacturer&#x2019;s instructions. Western blot was employed to confirm the presence of markers, such as positive expression of TSG101, CD81, and CD9, and negative expression of Calnexin.</p>
<p>Next process involved incubating EVs with DIO (Beyotime, China) for 15&#xa0;min at room temperature. After washing with PBS and centrifuging at 100,000 &#xd7; <italic>g</italic> for 70&#xa0;min, the various BMSC-EVs were suspended in basal medium (10<sup>10</sup>/mL) and incubated with MC3T3-E1 cells for 48&#xa0;h at 37&#xa0;&#xb0;C (<xref ref-type="bibr" rid="B55">Wu et al., 2019</xref>; <xref ref-type="bibr" rid="B30">Li et al., 2022</xref>). Then stained by 0.1&#xa0;g/mL DAPI (Beyotime, China) for 5&#xa0;min, the MC3T3-E1 cells were placed under a confocal system of high-content screening (PE/Opera Phenix Plus, PerkinElmer, United States) for image capture.</p>
</sec>
<sec id="s2-4">
<title>2.4 Cell culture and dexamethasone stimulation</title>
<p>MC3T3-E1 osteoblastic cells were purchased from CCTCC (Subclone 14, GDC0188, China) and cultured in &#x3b1;-MEM supplemented with 10% FBS (Lonsera, Uruguay) and 1% penicillin-streptomycin in humidified incubators at 37&#xa0;&#xb0;C and 5% CO<sub>2</sub>. Cells were treated with 10&#xa0;&#x3bc;M DEX (TargetMol, China) <italic>in vitro</italic> to mimic the disease for 24&#xa0;h (<xref ref-type="bibr" rid="B47">Tao et al., 2017</xref>). BMSC-EVs, BMSC-EVs<sup>PEMFs (1 mT)</sup>, BMSC-EVs<sup>PEMFs (1.6 mT)</sup> and BMSC-EVs<sup>PEMFs (3 mT)</sup> at a dosage of 10<sup>10</sup>/mL were co-cultured with MC3T3-E1 osteoblastic cells for 48&#xa0;h.</p>
</sec>
<sec id="s2-5">
<title>2.5 Annexin V staining</title>
<p>Annexin V-FITC/PI apoptosis detection kit (Cell Signaling Technology, Danvers, MA, United States) was used for distinguishing between live, early apoptotic, and late apoptotic/necrotic cells (<xref ref-type="bibr" rid="B66">Zhu et al., 2021</xref>). Then the results were obtained using a flow cytometer (FACSAria III, BD, United States).</p>
</sec>
<sec id="s2-6">
<title>2.6 Alkaline phosphatase (ALP) and alizarin red staining (ARS) staining</title>
<p>Following osteogenic induction for periods of 7 and 21&#xa0;days, the cells were fixed with a solution of 4% paraformaldehyde (Biosharp, China). Subsequently, alkaline phosphatase (ALP) activity was assessed with a BCIP/NBT staining kit (Beyotime, China). To evaluate the formation of mineralized nodules, Alizarin Red S (ARS) staining (Beyotime, China) was conducted for 20&#xa0;min. The cells were then examined microscopically (Ti2, Nikon, United States) to assess osteogenic differentiation.</p>
</sec>
<sec id="s2-7">
<title>2.7 Western blotting analysis</title>
<p>Total proteins were extracted and examined using a protein extraction kit (Beyotime, China) and BCA method with a commercial kit (Thermo Fisher Scientific, United States) following established protocols. Then the proteins were separated using 10% SDS-PAGE (EpiZyme, China) and were then transferred onto polyvinylidene fluoride membranes with a pore size of 0.22&#xa0;&#x3bc;m. GAPDH was used for normalization. The experiments were performed in triplicate. The information concerning the antibodies used and their concentrations is presented in <xref ref-type="sec" rid="s13">Supplementary Table S2</xref>.</p>
</sec>
<sec id="s2-8">
<title>2.8 Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title>
<p>Total RNA was extracted with TRIzol reagent (Takara, Japan) from femoral heads and cultured cells, followed by reverse transcription to generate the first-strand cDNA using the Stand cDNA Synthesis SuperMix for qPCR Kit (Hifair III, Yeasen, China). PCR was conducted with the SYBR Green PCR master mix (HieffUNICON, Yeasen, China) utilizing a Bio-Rad CFX Connect real-time system (Bio-Rad, United States). Primer sequences are shown in <xref ref-type="sec" rid="s13">Supplementary Table S3</xref> and <xref ref-type="sec" rid="s13">Supplementary Table S4</xref>. The experiments were conducted in three replicates, and the data were analyzed by the 2<sup>&#x2212;&#x394;&#x394;CT</sup> method (<xref ref-type="bibr" rid="B2">Bern&#xe1;ldez et al., 2017</xref>).</p>
</sec>
<sec id="s2-9">
<title>2.9 Immunofluorescence analysis</title>
<p>Briefly, after being fixed, permeabilization and blocked, cells were incubated with primary antibodies: RUNX2, CON, RIPK1 or RIPK3 (1:200) (Beyotime, China). After being washed twice, the 96-well (PerkinElmer, United States) were subsequently treated with secondary goat anti-rabbit antibody (Alexa Fluor 488, Beyotime, China) at 37&#xa0;&#xb0;C for 1&#xa0;h. F-action and nuclei were co-stained for 20&#xa0;min with phalloidin (Actin-Tracker Red-594, Beyotime, China) and for 5&#xa0;min with DAPI, respectively.</p>
</sec>
<sec id="s2-10">
<title>2.10 RNA sequencing analysis</title>
<p>MC3T3-E1 cells treated with DEX or with proper EVs were compared. The sequence and filtering of clean reads were completed as previously described (<xref ref-type="bibr" rid="B49">Thompson et al., 2020</xref>). A cDNA library was generated using pooled RNA from two groups and sequenced utilizing the Illumina Novaseq&#x2122; 6000 sequencing platform (LC-Biotechnology CO., Ltd., Hangzhou, China) (<xref ref-type="bibr" rid="B24">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="B25">Kovaka et al., 2019</xref>). The raw sequence data have been submitted to the NCBI Short Read Archive (SRA) with the access number PRJNA1115973 (SAMN41518211-SAMN41518218). DESeq2 soft were utilized for analyzing the differentially expressed genes (DEGs). A volcano plot was performed by DEGs (Fold change &#x2265; 1.1 and false discovery rate (FDR) &#x3c; 0.1). DEGs were included for further functional analysis based on GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases.</p>
</sec>
<sec id="s2-11">
<title>2.11 Animal experiments</title>
<p>Approval for the animal experiments in this study was obtained from the Animal Ethical Committee. According to the guidelines for sample size calculations of Boston University and the study of Li and colleagues (<xref ref-type="bibr" rid="B31">Li et al., 2023</xref>), a total of 40 male SD rats (8&#xa0;weeks, male; purchased from HFKbio, China) were randomly divided into four groups (n &#x3d; 10) by simple randomization method, using a computer-generated table: normal (saline); MPS (Methylprednisolone hemisuccinate (MPS) &#x2b; saline); EVs<sup>No PEMFs</sup> (MPS&#x2b;EVs without preconditioning); and EVs<sup>PEMFs</sup> (MPS&#x2b;proper EVs<sup>PEMFs</sup>). The model and treatment protocols were established as previously reported. MPS (20&#xa0;mg/kg per day; TargetMol, China) or saline was injected intramuscularly into rats to induce ONFH during the first 3&#xa0;days of each week, continuing until the third week (<xref ref-type="bibr" rid="B64">Zhao et al., 2023</xref>). Beginning with the first injection of MPS, the EVs (100&#xa0;&#x3bc;L, 10<sup>10</sup> particles) were injected into the rats through the tail vein, thrice a week for 3&#xa0;weeks (<xref ref-type="bibr" rid="B6">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="B16">Guo et al., 2016</xref>). Five rats were dissected after isoflurane overdose for examination at 2&#xa0;weeks and the remaining rats were dissected at 6&#xa0;weeks after the first injection (<xref ref-type="bibr" rid="B7">Chen et al., 2022</xref>).</p>
</sec>
<sec id="s2-12">
<title>2.12 Micro-CT analysis</title>
<p>The femoral heads were scanned using micro-CT (Quantum GX, PerkinElmer, United States), with a voltage of 80&#xa0;kV and a current of 100&#xa0;&#x3bc;A. The scanner software was configured to achieve high resolution, utilizing a voxel size of 20&#xa0;&#x3bc;m and a field of view measuring 10&#xa0;mm. Three-dimensional (3D) images of the femoral heads were reconstructed and the bone volume/total volume (BV/TV), bone surface/bone volume (BS/BV), bone mineral density (BMD), trabecular number (Tb.N), trabecular thickness (Tb.Th), and trabecular separation (Tb.Sp) of the region of interest was calculated by Caliper Analyze (BIR, Mayo Clinic, United States).</p>
</sec>
<sec id="s2-13">
<title>2.13 Histological and immunohistochemistry analysis</title>
<p>The specimens for histological evaluation, including hematoxylin and eosin (H&#x26;E) and Masson&#x2019;s trichrome staining, were processed according to earlier protocols (<xref ref-type="bibr" rid="B29">Li G. et al., 2020</xref>). Images were captured using a light optical microscope (Ni-E, Nikon, United States). The specimens were decalcified, fixed in formaldehyde, dehydrated, and embedded in paraffin. After dewaxing and antigen retrieval, 10% bovine serum albumin was used to block nonspecific binding for 30&#xa0;min. The sections were incubated overnight at 4&#xa0;&#xb0;C with primary antibodies (seen in <xref ref-type="sec" rid="s13">Supplementary Table S5</xref>) and then with an HRP-conjugated secondary antibody (PV9001, ZSGB Biotechnology, China), counterstained with hematoxylin. All tests were done on at least three sections per specimen and regions of interesting were selected randomly by two independent observers to ensure consistency and representativeness while minimizing sampling bias.</p>
</sec>
<sec id="s2-14">
<title>2.14 Statistical analysis</title>
<p>The data are expressed as the mean &#xb1; standard deviation (SD) based on a minimum of three separate experiments. Statistical analysis was conducted using GraphPad Prism 9 (La Jolla, CA, United States). One-way ANOVA was used to compare group means, with Bonferroni&#x2019;s <italic>post hoc</italic> analysis for significance between pairs. A <italic>p</italic>-value &#x3c;0.05 was deemed significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Characterization of BMSCs and PEMFs with different amplitudes preconditioned BMSC-EVs</title>
<p>BMSCs expressed CD44 and CD90, while showing no expression of CD34 and CD45 (<xref ref-type="fig" rid="F1">Figure 1A</xref>). They demonstrated the capacity to differentiate into adipocytes, osteoblasts, or chondrocytes upon appropriate induction (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The microscopy view indicated typical shape of BMSCs, and good viability from colonies (<xref ref-type="sec" rid="s13">Supplementary Figure S4A</xref>). The EVs (BMSC-EVs and BMSC-EVs<sup>PEMFs</sup>) were smaller than 200&#xa0;nm (<xref ref-type="fig" rid="F1">Figure 1C</xref>) with a mean diameter of 97.30 &#xb1; 11.34&#xa0;nm, 95.00 &#xb1; 8.26&#xa0;nm, 103.50 &#xb1; 10.20&#xa0;nm and 99.60 &#xb1; 6.78&#xa0;nm in BMSC-EVs<sup>No PEMFs</sup>, BMSC-EVs<sup>PEMFs (1 mT)</sup>, BMSC-EVs<sup>PEMFs (1.6 mT)</sup>, and BMSC-EVs<sup>PEMFs (3 mT)</sup> group, respectively. The EVs exhibited a round-shaped morphology (<xref ref-type="fig" rid="F1">Figure 1D</xref>). No obvious difference of particles numbers was detected (<italic>p</italic> &#x3e; 0.05, <xref ref-type="sec" rid="s13">Supplementary Figure S4B</xref>). Moreover, particles were positive for EVs markers including CD9, CD81, and TSG101, and negative for Calnexin (endoplasmic marker, <xref ref-type="sec" rid="s13">Supplementary Figure S4C</xref>). The result of immunofluorescence manifested that the DIO-labeled EVs could transfer to the perinuclear region of BMSCs after incubation with BMSCs (<xref ref-type="fig" rid="F1">Figure 1E</xref>). The viability of osteoblasts was not reduced when incubated with EVs and most EVs transferred to osteoblasts after 24&#xa0;h incubation (<xref ref-type="sec" rid="s13">Supplementary Figure S4D</xref>). These results indicated that BMSC-EVs were isolated and incorporated into MC3T3-E1 cells.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Characterization of rat BMSC-EVs under different amplitudes of PEMFs exposure system and uptake of BMSC-EVs. <bold>(A)</bold> Flow cytometric analysis of the surface markers of BMSCs. <bold>(B)</bold> The osteogenic differentiation, adipogenic differentiation, and chondrogenic differentiation of MSCs. Scale bars: 500&#xa0;&#x3bc;m (white), 200&#xa0;&#x3bc;m (black), and 100&#xa0;&#x3bc;m (blue). <bold>(C)</bold> The particle size distribution of BMSC-EVs with different parameters of PEMFs. <bold>(D)</bold> A representative TEM image of BMSC-EVs from supernatant under different parameters of PEMFs. White arrows: representative images of BMSC-EVs. Scale bars: 200&#xa0;nm. <bold>(E)</bold> Cellular uptake assay by the confocal system of high-content screening demonstrated uptake of BMSC-EVs by MC3T3-E1 cells after 2, 24, and 48&#xa0;h (BMSC-EVs: green; MC3T3-E1 cytoskeleton: red; MC3T3-E1 nucleus: blue). Scale bars: 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g001.tif">
<alt-text content-type="machine-generated">The image contains several panels labeled A through E. Panel A displays flow cytometry histograms showing expression of CD markers with different percentages. Panel B shows staining images for osteogenic, adipogenic, and chondrogenic differentiation. Panel C presents line graphs showing data related to PEMFs (pulsed electromagnetic fields) at different intensities. Panel D features electron microscopy images with arrows highlighting differences with and without PEMFs at various intensities. Panel E illustrates fluorescence images showing the effect of different PEMF treatments over time, marked as Merge and EVs layers with DAPI/F-actin/EVs staining.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 PEMFs with 3&#xa0;mT preconditioned BMSC-EVs enhanced the osteogenesis of MC3T3-E1 cells</title>
<p>All intervention groups displayed an enhancement of osteogenic activity, with the effect of BMSC-EVs<sup>PEMFs (3 mT)</sup> being significantly stronger than that of different intensities and BMSC-EVs<sup>No PEMFs</sup>. The activity of ALP was higher in BMSC-EVs<sup>PEMFs (3 mT)</sup> group (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F2">Figures 2A,B</xref>). The protein level of RUNX2 after 7-day induce were significantly higher than other groups with DEX (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F2">Figures 2C,D</xref>). RT-qPCR determined that the expression of <italic>Runx2</italic> and <italic>Bmp2</italic> in BMSC-EVs<sup>PEMFs (3 mT)</sup> group were significantly higher than that in the DEX, EVs, and other amplitudes groups (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F2">Figure 2I</xref>). Subsequently, the result of ARS staining after 21-day differentiation demonstrated that the calcium nodules in EVs, BMSC-EVs<sup>PEMFs (1.6 mT)</sup> and BMSC-EVs<sup>PEMFs (3 mT)</sup> groups were significantly higher than that in the DEX groups (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F2">Figures 2E,F</xref>). OCN was high-expressed in BMSC-EVs<sup>PEMFs (3 mT)</sup> group than EVs and BMSC-EVs<sup>PEMFs (1.6 mT)</sup> group (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F2">Figures 2G,H</xref>). Moreover, the expression of <italic>Ocn</italic> and <italic>Col1a1</italic> in the BMSC-EVs<sup>PEMFs (3 mT)</sup> group was be increased comparing to DEX, EVs, and other amplitude groups (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F2">Figure 2i</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The osteogenesis of MC3T3-E1 cells treated with different BMSC-EVs<sup>PEMFs</sup>. <bold>(A)</bold> Assessment of ALP by BCIP/NBT. Scale bars: 500&#xa0;&#x3bc;m, and <bold>(B)</bold> Quantification of ALP activity. <bold>(C)</bold> Immunofluorescence images of expression in MC3T3-E1 cells after different treatments for 7&#xa0;days (RUNX2: green; cytoskeleton: red; nucleus: blue; 3D thermal imaging: reconstruction of fluorescence intensity of RUNX2). Scale bar: 50&#xa0;&#x3bc;m, and <bold>(D)</bold> Quantitative analysis of immunofluorescence results of RUNX2. <bold>(E)</bold> Assessment of mineralization by alizarin red staining. Scale bar: 500&#xa0;&#x3bc;m, and <bold>(F)</bold> Quantitative analysis of alizarin red staining. <bold>(G)</bold> Immunofluorescence images of expression in MC3T3-E1 cells after different treatments for 21&#xa0;days (OCN: green; cytoskeleton: yellow; nucleus: blue; 3D thermal imaging: reconstruction of fluorescence intensity of OCN). Scale bar: 50&#xa0;&#x3bc;m. <bold>(H)</bold> Quantitative analysis of immunofluorescence results of OCN. <bold>(I)</bold> Expression of Runx2, Bmp2, Ocn and Col1a1 mRNA was measured by RT-qPCR. Bars represent mean and SD. Compared with each group as determined by one-way ANOVA and <italic>post hoc</italic> analysis, where &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g002.tif">
<alt-text content-type="machine-generated">Scientific research figure displaying various experiments on cells under different conditions. Panels A, C, E, and G show microscopy images depicting cell morphology and protein staining under conditions such as normal, DEX, and different intensity electromagnetic fields. Panels B, D, F, and H present bar and violin plots comparing different metrics across conditions. Panel I includes scatter plots showing relative mRNA expression levels of RUNX2, BMP2, COL1a1, and OCN, with statistical significance indicated. The sub-panels illustrate variations in cellular responses and expressions under these experimental setups, demonstrated through color-coded molecular markers and quantifications.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Comparison of mRNAs revealed the mechanism of BMSC-EVs<sup>PEMFs (3 mT)</sup> therapy</title>
<p>Based on mentioned results, BMSC-EVs<sup>PEMFs (3 mT)</sup> and the DEX group were conducted for RNA sequencing. The heatmap demonstrated the top 100 genes according to relative expression (<xref ref-type="fig" rid="F3">Figure 3A</xref>). The volcano plot analysis indicated 58 DEGs were upregulated and 54 DEGs were downregulated in the DEX compared with the BMSC-EVs<sup>PEMFs (3 mT)</sup> (<xref ref-type="fig" rid="F3">Figure 3B</xref>). There results confirmed that the programmed cell death-related gene, <italic>Ripk3</italic>, was significantly reduced in BMSC-EVs<sup>PEMFs (3 mT)</sup> group. Furthermore, GO database analysis indicated mechanism involved in bone development and cell death (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Reactome pathway database analysis determined several pathways were involved, such as ECM synthesis, metabolism, immune system, collagen synthesis (<xref ref-type="fig" rid="F3">Figure 3D</xref>). The relevant enriched KEGG pathways analysis in <xref ref-type="fig" rid="F3">Figure 3E</xref> indicated that the regulated genes clustered in cell adhesion and communication, immune-inflammatory regulation, and bone mentalism (such as TGF-beta, Wnt, and Hippo signaling pathways).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>RNA-Seq analysis in MC3T3-E1 treated with BMSC-EVs<sup>PEMFs (3 mT)</sup> and negative control. <bold>(A)</bold> Heatmap depicting the expression of different expression genes (DEGs) in groups, which was extracted from DEX group (n &#x3d; 4) and DEX with EVs<sup>PEMFs</sup> <sup>(3 mT)</sup> group (n &#x3d; 4). The top 100 mRNAs with the highest fold-change were identified, and cell programmed death-related gene is circled. <bold>(B)</bold> Volcanic map of DEGs between groups. Red spots represent upregulated genes and blue spots represent downregulated genes. <bold>(C)</bold> Enrichment plot of GO annotations. The top significant GO enrichments of the target genes of the DEGs are shown. The correlation between mRNA and related biological processes, cellular component, and molecular function was measured using the negative log<sub>10</sub> of the q-value. GO, Gene Ontology. <bold>(D)</bold> The Reactome enrichment analysis scatter plot. <bold>(E)</bold> KEGG enrichment for groups. The top 8 most relevant KEGG pathways of the DEGs. KEGG, Kyoto Encyclopedia of Genes and Genomes.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g003.tif">
<alt-text content-type="machine-generated">Clustered heatmap, volcano plot, and bar plots from a bioinformatics analysis. Panel A shows a heatmap with hierarchical clustering of gene expression data, colored from blue to red. Panel B presents a volcano plot highlighting significantly upregulated and downregulated genes. Panel C depicts a Gene Ontology (GO) enrichment bar plot categorizing terms under biological processes, cellular components, and molecular functions. Panel D illustrates another enrichment bar plot with various terms. Panel E shows a KEGG enrichment bar plot detailing cellular processes and pathways across different categories.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 BMSC-EVs<sup>PEMFs</sup> reduced the level of necroptosis via inhibition of RIPK1&#x2013;RIPK3&#x2013;MLKL signaling</title>
<p>Annexin V/PI staining indicated that higher percentage of cell with programmed cell death in the DEX group than that other groups and the BMSC-EVs<sup>PEMFs (3 mT)</sup> significantly ameliorated the ratio of dying cells (<italic>p</italic> &#x3c; 0.001, <xref ref-type="fig" rid="F4">Figures 4A,C</xref>). Western blot in <xref ref-type="fig" rid="F4">Figure 4B</xref> (full-length gels are presented in <xref ref-type="sec" rid="s13">Supplementary Figures S5&#x2013;S9</xref>) determined a decrease in RIPK1, RIPK3, and mixed lineage kinase domain-like (MLKL). Immunofluorescence analysis in <xref ref-type="fig" rid="F4">Figures 4E</xref>,<xref ref-type="fig" rid="F4">F</xref> and RT-qPCR (<xref ref-type="fig" rid="F4">Figure 4G</xref>) indicated, and RT-qPCR indicated BMSC-EVs<sup>PEMFs (3 mT)</sup> abolished the increase of RIPK3 and MLKL (<italic>p</italic> &#x3c; 0.001) than DEX group, suggesting a therapeutic effect on inhibiting necroptosis.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of the different BMSC-EV<sup>PEMFs</sup> on necroptosis of MC3T3-E1 cells and activation of the necroptosis pathway. <bold>(A)</bold> The programmed cell death of MC3T3-E1 cells estimated with Annexin V/PI staining and reflected in Q2, and <bold>(C)</bold> the rate of programmed cell death of MC3T3-E1 cells estimated with Annexin V/PI staining. <bold>(B)</bold> Representative western blots of RIPK1, RIPK3, and MLKL proteins in MC3T3-E1 cells treated with the BMSCs-EVs under different intensities of PEMFs. GAPDH was used as internal loading control (gel was cut at 70 and 40&#xa0;kDa and the original images are presented in <xref ref-type="sec" rid="s13">Supplementary Figures S5&#x2013;S9</xref>). <bold>(D)</bold> Relative protein immunofluorescence intensity of RIPK1 and RIPK3. <bold>(E,F)</bold> Immunofluorescence images of RIPK1 and RIPK3 expression in MC3T3-E1 cells after different treatments. (RIPK1/RIPK3: green; cytoskeleton: red; nucleus: blue; 3D thermal imaging: reconstruction of fluorescence intensity of RIPK1). Scale bar: 50&#xa0;&#x3bc;m. <bold>(G)</bold> Expression of <italic>Ripk1</italic>, <italic>Ripk3</italic>, and <italic>Mlkl</italic> mRNA was measured by RT-qPCR. Bars represent mean and SD. The significant difference was analyzed by one-way ANOVA and <italic>post hoc</italic> analysis, where &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g004.tif">
<alt-text content-type="machine-generated">Composite image showing experimental data on cell responses to different conditions. Panel A displays flow cytometry plots. Panel B shows Western blot results for proteins RIPK1, MLKL, RIPK3, and GAPDH. Panel C presents a bar graph with statistical analysis. Panel D displays a violin plot for fluorescence intensity. Panels E and F feature fluorescence microscopy images showing cell morphology with DAPI, F-actin, and RIPK1/RIPK3 staining; 3D surface plots are included. Panel G contains plots for Ripk1 and Ripk3 expression. Statistical significance is indicated with asterisks in some graphs.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 BMSC-EVs<sup>PEMFs (3 mT)</sup> improved bone morphology of the femoral head</title>
<p>ONFH rat models were used to investigate if BMSC-EVs<sup>PEMFs (3 mT)</sup> could effectively prevent the development of ONFH <italic>in vivo</italic> (<xref ref-type="fig" rid="F5">Figure 5A</xref>). The normal, MPS, EVs<sup>No PEMFs</sup>, and EVs<sup>PEMFs (3 mT)</sup> group were established for comparison, and the weights of each group were recorded (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Images of the coronal, sagittal, and transverse planes of micro-CT analyzing short-term effect srevealed that the MPS group suffered significant bone mineral loss, decreased bone density, and the presence of osteonecrosis-like structures below the epiphyseal line compared to the normal group. However, these adverse effects were somewhat improved in the EVs<sup>No PEMFs</sup> and EVs<sup>PEMFs (3 mT)</sup> groups, although the results still fell short of expectations (<xref ref-type="fig" rid="F5">Figure 5C</xref>). The BS/BV of the region of interest was significantly increased in EVs<sup>PEMFs (3 mT)</sup> group compared to EVs<sup>No PEMFs</sup> group (<italic>p</italic> &#x3c; 0.01, <xref ref-type="fig" rid="F5">Figure 5D</xref>). In the long-term observations, images of the planes revealed that the EVs<sup>PEMFs (3 mT)</sup> group displayed a compact and evenly distributed trabecular bone structure. This suggests that the EVs<sup>PEMFs (3 mT)</sup> eliminated the negative effect to the femoral head caused by MPS. However, the EVs<sup>No PEMFs</sup> still did not meet expectations (<xref ref-type="fig" rid="F5">Figure 5E</xref>). The BV/TV, BS/BV, Tb.Th, Tb.N and BMD were significantly increased in EVs<sup>PEMFs (3 mT)</sup> group compared to EVs<sup>No PEMFs</sup> group, while Tb.Sp was decreased (<italic>p</italic> &#x3c; 0.05, <xref ref-type="fig" rid="F5">Figure 5F</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Effect of the BMSC-EVs assessed by micro-CT images of the femoral heads. <bold>(A)</bold> Schematic display of methods and time nodes for injection <italic>in vivo</italic>. <bold>(B)</bold> The weight record of each group (week 1&#x2013;3: n &#x3d; 10; week 4&#x2013;7: n &#x3d; 5). <bold>(C)</bold> Micro-CT reconstructed images of femoral heads, including a coronal 2D image, a sagittal 2D image, a transverse section, and a 3D reconstruction of ROI at 2&#xa0;weeks after the first injection (short-term period), and <bold>(D)</bold> quantitative analysis. <bold>(E)</bold> Micro-CT reconstructed images of femoral heads, including a coronal 2D image, a sagittal 2D image, a transverse section, and a 3D reconstruction of ROI at 6 weeks after the first injection (long-term period) and <bold>(F)</bold> quantitative analysis of the ROI. n &#x3d; 5 per group. Bars represent mean and SD. The significant difference was analyzed by one-way ANOVA and <italic>post hoc</italic> analysis, where &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g005.tif">
<alt-text content-type="machine-generated">Experimental flowchart and data on rat models of ONFH. Panel A shows a timeline of procedures over weeks. Panel B displays a line graph comparing weight changes under different conditions over time. Panel C provides coronal, sagittal, and transverse micro-CT images of bone structure (short-term) in four groups: Normal, MPS, EVs with no PEMFs, and EVs with PEMFs at 3 mT. Panel D contains bar graphs of bone density and thickness metrics for each condition in Panel C. Panel E presents a long-term set of micro-CT images similar to Panel C, and Panel F includes related bar graphs analyzing bone density and structure.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 BMSC-EVs<sup>PEMFs (3 mT)</sup> inhibited necroptosis and promoted bone formation of femoral head</title>
<p>H&#x26;E staining <xref ref-type="fig" rid="F6">Figure 6A</xref> revealed significant formation of empty bone lacunae, localized disruption of bone trabeculae characterized by a sparse and disorganized structure, as well as the invasion of adipose tissue into the marrow cavity in the short-term samples of the femoral head from the MPS and EVs<sup>No PEMFs</sup> groups. Most areas of the femoral head in EVs<sup>PEMFs (3 mT)</sup> group also presented the above changes. Masson staining indicated some new bone trabeculae transitioning from blue to red in EVs<sup>PEMFs (3 mT)</sup> group. For dissection at long-term shown in <xref ref-type="fig" rid="F6">Figure 6B</xref>, HE staining revealed that the trabecular bone was still occupied by an abundance of cells resembling adipocytes, along with deteriorating cells exhibiting condensed nuclei and encircled by a lucid cytoplasmic area in MPS group, and the trabecular bone became sparse and thin in EVs<sup>No PEMFs</sup> group. In contrast, rats after the treatment of EVs<sup>PEMFs (3 mT)</sup> showed only slight osteonecrosis of the trabecular bone, as well as fewer empty lacunae and adipose cells. Short-term immunohistochemistry analysis revealed lower expression of MLKL, and higher expression of RUNX2 in EVs<sup>PEMFs (3 mT)</sup> group (<italic>p</italic> &#x3c; 0.05, <xref ref-type="fig" rid="F6">Figures 6C,E</xref>). For long-term, lower expression of RIPK1 and RIPK3, and higher expression of RUNX2 and OCN in EVs<sup>PEMFs (3 mT)</sup> group than others (<italic>p</italic> &#x3c; 0.05, <xref ref-type="fig" rid="F6">Figures 6D,F</xref>). Furthermore, more mRNA of <italic>Ripk1</italic>, <italic>Ripk3</italic>, and <italic>Mlkl</italic> were expressed in MPS group (<italic>p</italic> &#x3c; 0.05), and more mRNA of <italic>Ocn</italic> and <italic>Runx2</italic> were expressed in normal group than others (<italic>p</italic> &#x3c; 0.05) (<xref ref-type="fig" rid="F6">Figure 6G</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>The anti-necroptosis and osteogenesis-promoting effects of EVs on the rat model of ONFH. <bold>(A)</bold> Representative H&#x26;E and Masson staining images of femoral heads in rats receiving different treatments at week 2 and <bold>(B)</bold> Week 6 after the first injection. Scale bars: 750&#xa0;&#x3bc;m (black) and 100&#xa0;&#x3bc;m (white). <bold>(C)</bold> Representative immunohistochemical staining of RIPK1, RIPK3, MLKL, OCN, and ALP in samples from different groups at week 2 and <bold>(D)</bold> Week 6 after the first injection. Scale bars: 100&#xa0;&#x3bc;m. Black arrow: RIPK1, RIPK3, MLKL, OCN, or ALP positive cells. <bold>(E)</bold> Quantitative analysis of the level of RIPK1, RIPK3, MLKL, OCN, and ALP in femoral heads from each group at week 2 and <bold>(F)</bold> Week 6 after the first injection. The black arrow indicates the positive cells, n &#x3d; 5 per group. <bold>(G)</bold> Expression of <italic>Ripk1</italic>, <italic>Ripk3</italic>, <italic>Mlkl</italic>, <italic>Ocn</italic>, and <italic>Alp</italic> mRNA at week 2 and week 6 after the first injection was measured by RT-qPCR (n &#x3d; 5). Bars represent mean and SD. The significant difference was analyzed by one-way ANOVA and <italic>post hoc</italic> analysis, where &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g006.tif">
<alt-text content-type="machine-generated">Histological and statistical analysis of tissue samples in short-term and long-term experiments. Panels A and B show histological images with HE and Masson staining, comparing normal, MPS, EVs\(^\text{No&#xA0;PEMFs}\), and EVs\(^\text{PEMF(3&#xA0;mT)}\) conditions. Panels C and D depict immunohistochemical staining for RIPK1, RIPK3, MLKL, RUNX2, and OCN. Graphs E, F, and G display statistical analysis, with bar and scatter plots representing quantitative data under similar conditions, highlighting significant differences.</alt-text>
</graphic>
</fig>
<p>Immunohistochemical staining for CD31 and TRAP was conducted to investigate the distribution of blood vessels and osteoclasts within the femoral heads across various groups. The normal, EVs<sup>No PEMFs</sup>, and EVs<sup>PEMFs (3 mT)</sup> groups had higher expression of CD31, and the MPS group displayed the lowest levels (<xref ref-type="fig" rid="F7">Figure 7A</xref>). TRAP staining indicated that the osteoclasts in normal and EVs<sup>PEMFs</sup> group were inactive than others (<xref ref-type="fig" rid="F7">Figure 7B</xref>). The results confirmed that the MPS injections in rats led to a significant reduction in blood vessel formation and increased activity of osteoclasts in the femoral head. In contrast, BMSC-EVs<sup>PEMFs (3 mT)</sup> effectively mitigated blood vessel deficiency and osteoclast activity, avoiding the deterioration of ONFH. Additionally, HE staining of vital organs showed no significant biotoxicity from BMSC-EVs and BMSC-EVs<sup>PEMFs (3 mT)</sup> to, although nephrocalcinosis was observed in the MPS group (<xref ref-type="fig" rid="F7">Figure 7C</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>The effects of EVs on anti-osteoclasts, angiogenesis and important organs. <bold>(A)</bold> Representative immunohistochemical staining of Trap and CD31 in samples from different groups at week 2 and <bold>(B)</bold> week 6 after injection. Scale bars: 100&#xa0;&#x3bc;m. Black arrow: Trap/CD31-positive cells. <bold>(C)</bold> H&#x26;E staining of major organs (heart, liver, spleen, lung, and kidneys, respectively) at week 2 and week 6. Scale bars: 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fbioe-13-1655579-g007.tif">
<alt-text content-type="machine-generated">Histological images comparing tissues under different conditions and times. Panel A shows Trap and CD31 markers for Normal, MPS, EVs without PEMFs, and EVs with PEMFs (3 mT). Panel B presents results for the same conditions, showing notable staining differences. Panel C displays tissue samples (heart, liver, spleen, lung, kidney) in both short and long-term for each condition, illustrating variations in tissue morphology.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>In this study, we used the easily available BMSCs and manufactured PEMFs to engineer the EVs secreted by BMSCs. The optimal field amplitude might be 3&#xa0;mT, and BMSC-EVs<sup>PEMFs (3 mT)</sup> showed more positive potential for anti-necroptosis and osteogenesis. Additionally, we provided evidence that administering BMSC-EVs intravenously under PEMFs at a field amplitude of 3&#xa0;mT during the initial glucocorticoid exposure stages significantly inhibited trabecular bone cell necroptosis, restored compromised angiogenesis, and averted trabecular bone deterioration in the femoral heads of rats. Meanwhile, we identified the involvement of RIPK1, RIPK3, and MLKL proteins in the anti-necroptotic effects of BMSC-EVs<sup>PEMFs (3 mT)</sup> in cultured osteoblast precursors exposed to DEX and in ONFH rats induced by MPS. Our study indicates the promising prospect of BMSC-EVs as a nanoparticle-based tool for safeguarding against GC-induced ONFH. Furthermore, the EVs derived from BMSCs cultured under PEMFs at a field amplitude of 3&#xa0;mT enhanced the effects. Targeting molecules such as RIPK1, RIPK3, and MLKL could further enhance their protective functions, opening exciting avenues for research and potential treatments.</p>
<p>Previous studies more focused on the role of apoptosis in ONFH. <xref ref-type="bibr" rid="B61">Yang et al. (2021)</xref> and <xref ref-type="bibr" rid="B47">Tao et al. (2017)</xref> both focused on apoptosis and illustrated the mechanism by which apoptosis attenuates ONFH and that exosomes from platelet-rich plasma prevent apoptosis. Nonetheless, a recent study has demonstrated that necroptosis plays an important role in the development of ONFH (<xref ref-type="bibr" rid="B13">Fan et al., 2022</xref>). For musculoskeletal diseases, Yuan and their colleague have reported that bone marrow necroptosis can lead to myelodysplasia which was mediated by the over-expression of <italic>Ripk1</italic> (<xref ref-type="bibr" rid="B62">Yuan et al., 2019</xref>). RIPK1 is an important molecular activated by the death receptor and leads to the activity-dependent formation of a RIPK1-RIPK3-MLKL complex (also known as complex IIb). In addition to its role in necroptosis, Lawlor and colleagues reported that RIPK3 is associated with NLRP3 inflammasome. On the one hand, RIPK3 with active caspase-8 promoted apoptosis and NLRP3&#x2013;caspase-1 activation. On the other hand, in the absence of caspase-8, RIPK3 kinase activity and MLKL are essential for Toll-like receptor-induced NLRP3 activation (<xref ref-type="bibr" rid="B27">Lawlor et al., 2024</xref>). In our study, differences in Ripk3 expression were detected after the treatment of BMSC-EVs<sup>PEMFs (3 mT)</sup>. For ONFH, Dai et al. and their colleagues demonstrated necroptosis of osteoblasts mediated by RIPK1, RIPK3, and MLKL with relative resistance to apoptosis (<xref ref-type="bibr" rid="B9">Dai et al., 2020</xref>). Hence, we further investigated the changes in RIPK3 and MLKL, and focused on the Ripk1&#x2013;Ripk3&#x2013;Mlkl mediated necroptosis in ONFH.</p>
<p>EVs transfer into the extracellular space through the plasma membrane while protecting their contents by the lipid structure, hence inherently benefit from immune tolerance (<xref ref-type="bibr" rid="B48">Thakur et al., 2022</xref>). Previous studies have reported the therapeutic effects of EVs derived from CD34<sup>&#x2b;</sup> stem cells (<xref ref-type="bibr" rid="B67">Zuo et al., 2019</xref>), adipose-derived stem cells (<xref ref-type="bibr" rid="B40">Nan et al., 2021</xref>), BMSCs (<xref ref-type="bibr" rid="B28">Li L. et al., 2020</xref>), and synovial-derived MSCs (<xref ref-type="bibr" rid="B16">Guo et al., 2016</xref>) on preventing ONFH via increased proliferation and osteogenic differentiation of BMSCs. Our study focused on the function of osteoblasts, which are major mediator for bone formation (<xref ref-type="bibr" rid="B12">Dirckx et al., 2019</xref>). Additionally, an increasing number of researchers have focused on methods for enhancing the function of EVs. Chen et al. engineered EVs with hydrogel to improve bone repair capabilities (<xref ref-type="bibr" rid="B8">Chen et al., 2023</xref>). Besides tissue engineering, changing the condition of original cells also mediates the contents in EVs. Tian and colleagues harvested EVs from dental pulp stem cells subjected to hypoxic preconditioning. Their findings revealed that these hypoxia-derived EVs can promote the generation of M2 macrophages while concurrently suppressing osteoclastogenesis (<xref ref-type="bibr" rid="B50">Tian et al., 2023</xref>).</p>
<p>PEMFs seem to be convenient physical therapy for engineering EVs and enhancing the therapeutic role of EVs. PEMFs may activate the BMP2 pathway via notable Ca<sup>2&#x2b;</sup> oscillations with robust Ca<sup>2&#x2b;</sup> spikes (<xref ref-type="bibr" rid="B59">Yan et al., 2022</xref>; <xref ref-type="bibr" rid="B46">So et al., 2000</xref>). However, the parameters of PEMFs are always controversial and different to be consistent for targeting varied cells. Wong and their colleague indicated that a single 10-min exposure of donor myoblast cultures to 15 or 50&#xa0;Hz with 1.5&#xa0;mT amplitude PEMFs can stimulate EVs release and the conditioned medium with EVs demonstrate similar growth and survival potentials when compared to traditional fetal bovine serum (<xref ref-type="bibr" rid="B54">Wong et al., 2022</xref>). Our previous study investigated the effect of MSC-EVs under PEMFs exposure at 1&#xa0;mT amplitude with different frequencies of 15, 45, and 75&#xa0;Hz on reducing IL-1&#x3b2;-induced chondrocyte inflammation. The results demonstrated that PEMFs with 75&#xa0;Hz obviously regulated the biofunction of MSC-EVs (<xref ref-type="bibr" rid="B58">Xu et al., 2022</xref>). Parate and their colleague investigated the effect of PEMFs at a frequency of 15&#xa0;Hz with 1&#x2013;4&#xa0;mT amplitude on BMSC chondrogenic differentiation, and the RT-qPCR and secretome analysis indicated that 3&#xa0;mT was the best amplitude for two-dimensional culture (<xref ref-type="bibr" rid="B42">Parate et al., 2020</xref>). In this study, we chose the PEMFs at a frequency of 75&#xa0;Hz with 1&#x2013;3&#xa0;mT amplitude, and we found 3&#xa0;mT amplitude might be the optimal intensity for osteogenic differentiation of osteoblasts. The conclusion was partly similar to Parate and their colleague, but the PEMFs exposure frequency was different, which might be caused by the character of targeted cells. Our results evidenced that BMSC-EVs<sup>PEMFs (3 mT)</sup> effectively alleviate the development of ONFH by promoting osteogenesis and inhibiting necroptosis of osteoblasts via Ripk1&#x2013;Ripk3&#x2013;Mlkl signaling, which still warrants future investigation.</p>
<p>Although we demonstrated the effect of BMSC-EVs<sup>PEMFs (3 mT)</sup>, several limitations were shown in this study, Initially, we established MPS-induced ONFH models in SD rats through intramuscular injections of MPS for three consecutive days each week over a 3-week period. We observed characteristic pathological features of ONFH, including notable and consistent bone lesions in the femoral heads without femoral head collapse. We subsequently administered the same types of therapies via tail vein injection. This type of injection can only be used for the early stage of the disease or for preventing ONFH, since the damage to blood vessels of the femoral head worsens with the progression of the disease. Moreover, we only tested CD31 while more angiogenic and vasculogenic markers and functional assays should be conducted for a comprehensive understanding of vascular responses in osteonecrosis. It remains unclear whether BMSC-EVs<sup>PEMFs (3 mT)</sup> could effectively attenuate glucocorticoid-induced ONFH in advanced stages. Finally, further studies are needed to comprehensively understand the mechanisms of PEMFs and the changes in EVs derived from cells under PEMFs exposure.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>To avert the onset and slow the progression of ONFH, we implemented the PEMFs exposure system as a convenient physical therapy to engineer the EVs secreted by BMSCs. A novel BMSC-EVs<sup>PEMFs</sup> was successfully collected with cell-entrance abilities. Cell experiments demonstrated that BMSC-EVs with 3&#xa0;mT amplitude PEMFs could markedly increase the capacity of osteogenesis and inhibit necroptosis of glucocorticoids-induced osteoblasts via the Ripk1&#x2013;Ripk3&#x2013;Mlkl signaling. In ONFH rat models, we further confirmed the outstanding therapeutic efficacy of EVs derived from BMSCs under PEMFs exposure at 3&#xa0;mT amplitude in the prevention of ONFH. Therefore, the PEMFs exposure system shows great promise as a physical agent. The notable preventive effects of EVs derived from BMSCs under PEMFs exposure at 3&#xa0;mT on ONFH offer exciting new insights and innovative ideas for treating ONFH and other conditions related to osteogenesis and necroptotic disorders.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found here: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/sra/PRJNA1115973">https://www.ncbi.nlm.nih.gov/sra/PRJNA1115973</ext-link>.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by the Animal Ethical Committee at West China Hospital of Sichuan University (Ethics Number: 20230227004). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>XX: Conceptualization, Investigation, Methodology, Visualization, Writing &#x2013; original draft. JZ: Investigation, Writing &#x2013; review and editing. XW: Investigation, Methodology, Writing &#x2013; review and editing. HH: Supervision, Writing &#x2013; review and editing. CH: Conceptualization, Funding acquisition, Supervision, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by the National Natural Science Foundation of China (82272599), and the 1.3.5 Project for Disciplines of Excellence of West China Hospital (ZYGD23014). The funders played no role in the design, conduct, or reporting of this study.</p>
</sec>
<ack>
<p>We gratefully acknowledge the technical assistance of the Core Facility of West China Hospital (Li Chai, Yi Li, Xing Xu, Cong Li), and the Animal Imaging Core Facilities of West China Hospital (Sheng-Lan You and Jie Tu). We want to express our gratitude for the drawing materials provided by BioRender.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2025.1655579/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2025.1655579/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s14">
<title>Abbreviations</title>
<p>ONFH, Osteonecrosis of the femoral head; BMSC-EVs, Extracellular vesicles derived from bone marrow mesenchymal stromal cells; EVs, Extracellular vesicles; PEMFs, Pulsed electromagnetic fields; BMSCs, Bone marrow mesenchymal stromal cells; BMSC-EVs<sup>PEMFs</sup>, PEMFs preconditioned BMSCs-EVs; mT, milli Tesla; RIPK, Receptor-interacting protein kinase; DEX, Dexamethasone; MLKL, Mixed lineage kinase domain-like; ARS, Alizarin red staining; TEM, Transmission electron microscopy; NTA, Nanoparticle trafficking analysis; ALP, Alkaline phosphatase; HRP, Horseradish peroxidase; RT-qPCR, Reverse transcription-quantitative polymerase chain reaction; SD, Sprague-Dawley; MPS, Methylprednisolone hemisuccinate; BV/TV, Bone volume/total volume; BS/BV, Bone surface/bone volume; BMD, Bone mineral density; Tb.N, Trabecular number; Tb.Th, Trabecular thickness; Tb.Sp, Trabecular separation; H&#x26;E, Hematoxylin and eosin; SRA, Short Read Archive; DEGs, Differentially expressed genes; KEGG, Kyoto Encyclopedia of genes and genomes.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aghaloo</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Chaichanasakul</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bezouglaia</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dry</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Osteogenic potential of mandibular vs. long-bone marrow stromal cells</article-title>. <source>J. Dent. Res.</source> <volume>89</volume> (<issue>11</issue>), <fpage>1293</fpage>&#x2013;<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1177/0022034510378427</pub-id>
<pub-id pub-id-type="pmid">20811069</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bern&#xe1;ldez</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>C&#xf3;rdoba</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Al&#xed;a</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Selection of reference genes to quantify relative expression of ochratoxin A-related genes by Penicillium nordicum in dry-cured ham</article-title>. <source>Food Microbiol.</source> <volume>68</volume>, <fpage>104</fpage>&#x2013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2017.07.001</pub-id>
<pub-id pub-id-type="pmid">28800817</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boulestreau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Maumus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jorgensen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>No&#xeb;l</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Extracellular vesicles from mesenchymal stromal cells: therapeutic perspectives for targeting senescence in osteoarthritis</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>175</volume>, <fpage>113836</fpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2021.113836</pub-id>
<pub-id pub-id-type="pmid">34166759</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celik</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Franco-Obreg&#xf3;n</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Directionalities of magnetic fields and topographic scaffolds synergise to enhance MSC chondrogenesis</article-title>. <source>Acta Biomater.</source> <volume>119</volume>, <fpage>169</fpage>&#x2013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2020.10.039</pub-id>
<pub-id pub-id-type="pmid">33130304</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Greenspan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gershwin</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis</article-title>. <source>J. Autoimmun.</source> <volume>110</volume>, <fpage>102460</fpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2020.102460</pub-id>
<pub-id pub-id-type="pmid">32307211</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S.-S.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.-K.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>M.-J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Extracellular vesicles from human urine-derived stem cells inhibit glucocorticoid-induced osteonecrosis of the femoral head by transporting and releasing pro-angiogenic DMBT1 and anti-apoptotic TIMP1</article-title>. <source>Acta Biomater.</source> <volume>111</volume>, <fpage>208</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2020.05.020</pub-id>
<pub-id pub-id-type="pmid">32447063</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis</article-title>. <source>Sci. Adv.</source> <volume>8</volume> (<issue>15</issue>), <fpage>eabg8335</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abg8335</pub-id>
<pub-id pub-id-type="pmid">35417243</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Engineered exosome-functionalized extracellular matrix-mimicking hydrogel for promoting bone repair in glucocorticoid-induced osteonecrosis of the femoral head</article-title>. <source>ACS Appl. Mater Interfaces</source> <volume>15</volume> (<issue>24</issue>), <fpage>28891</fpage>&#x2013;<lpage>28906</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.3c01539</pub-id>
<pub-id pub-id-type="pmid">37305922</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>Enterococcus faecalis</italic> induces necroptosis in human osteoblastic MG63 cells through the RIPK3/MLKL signalling pathway</article-title>. <source>Int. Endod. J.</source> <volume>53</volume> (<issue>9</issue>), <fpage>1204</fpage>&#x2013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1111/iej.13323</pub-id>
<pub-id pub-id-type="pmid">32379949</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daltro</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Fortuna</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Salles</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Carreira</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study</article-title>. <source>Stem Cell Res. Ther.</source> <volume>6</volume> (<issue>1</issue>), <fpage>110</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-015-0105-2</pub-id>
<pub-id pub-id-type="pmid">26021713</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debbi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Safina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Levenberg</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Boosting extracellular vesicle secretion</article-title>. <source>Biotechnol. Adv.</source> <volume>59</volume>, <fpage>107983</fpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2022.107983</pub-id>
<pub-id pub-id-type="pmid">35588952</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dirckx</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moorer</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Clemens</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Riddle</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The role of osteoblasts in energy homeostasis</article-title>. <source>Nat. Rev. Endocrinol.</source> <volume>15</volume> (<issue>11</issue>), <fpage>651</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-019-0246-y</pub-id>
<pub-id pub-id-type="pmid">31462768</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The protective effect of DNA aptamer on osteonecrosis of the femoral head by alleviating TNF-&#x3b1;-mediated necroptosis via RIP1/RIP3/MLKL pathway</article-title>. <source>J. Orthop. Transl.</source> <volume>36</volume>, <fpage>44</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2022.07.001</pub-id>
<pub-id pub-id-type="pmid">35919280</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Fibroblast growth factor 23 inhibition attenuates steroid-induced osteonecrosis of the femoral head through pyroptosis</article-title>. <source>Sci. Rep.</source> <volume>14</volume> (<issue>1</issue>), <fpage>16270</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-66799-z</pub-id>
<pub-id pub-id-type="pmid">39009650</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Administration of necrostatin-1 ameliorates glucocorticoid-induced osteonecrosis of the femoral head in rats</article-title>. <source>J. Mol. Histol.</source> <volume>54</volume> (<issue>3</issue>), <fpage>207</fpage>&#x2013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1007/s10735-023-10124-x</pub-id>
<pub-id pub-id-type="pmid">37156987</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C. Q.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Exosomes from human synovial-derived mesenchymal stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head in the rat</article-title>. <source>Int. J. Biol. Sci.</source> <volume>12</volume> (<issue>10</issue>), <fpage>1262</fpage>&#x2013;<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.16150</pub-id>
<pub-id pub-id-type="pmid">27766040</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C. Q.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model</article-title>. <source>Theranostics</source> <volume>7</volume> (<issue>1</issue>), <fpage>81</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.7150/thno.16803</pub-id>
<pub-id pub-id-type="pmid">28042318</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Engineered plant extracellular vesicles for autoimmune diseases therapy</article-title>. <source>Nano Res.</source> <volume>17</volume> (<issue>4</issue>), <fpage>2857</fpage>&#x2013;<lpage>2873</lpage>. <pub-id pub-id-type="doi">10.1007/s12274-023-6112-1</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannon</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guyatt</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>V. K.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>2023 American college of rheumatology and American association of hip and knee surgeons clinical practice guideline for the optimal timing of elective hip or knee arthroplasty for patients with symptomatic moderate&#x2010;to&#x2010;severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis for whom nonoperative therapy is ineffective</article-title>. <source>Arthritis Rheumatol.</source> <volume>75</volume> (<issue>11</issue>), <fpage>1877</fpage>&#x2013;<lpage>1888</lpage>. <pub-id pub-id-type="doi">10.1002/art.42630</pub-id>
<pub-id pub-id-type="pmid">37746897</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Quan</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head</article-title>. <source>J. Cell. Mol. Med.</source> <volume>24</volume> (<issue>19</issue>), <fpage>11512</fpage>&#x2013;<lpage>11523</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.15766</pub-id>
<pub-id pub-id-type="pmid">32871042</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Combined effects of low-frequency pulsed electromagnetic field and melatonin on ovariectomy-induced bone loss in mice</article-title>. <source>Bioelectromagnetics</source> <volume>42</volume> (<issue>8</issue>), <fpage>616</fpage>&#x2013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1002/bem.22372</pub-id>
<pub-id pub-id-type="pmid">34516671</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Enhanced effect of combining bone marrow mesenchymal stem cells (BMMSCs) and pulsed electromagnetic fields (PEMF) to promote recovery after spinal cord injury in mice</article-title>. <source>MedComm (2020)</source> <volume>3</volume> (<issue>3</issue>), <fpage>e160</fpage>. <pub-id pub-id-type="doi">10.1002/mco2.160</pub-id>
<pub-id pub-id-type="pmid">35949547</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Motomura</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ikemura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Differences in the microarchitectural features of the lateral collapsed lesion between osteonecrosis and subchondral insufficiency fracture of the femoral head</article-title>. <source>Bone</source> <volume>141</volume>, <fpage>115585</fpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2020.115585</pub-id>
<pub-id pub-id-type="pmid">32795680</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Paggi</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title>. <source>Nat. Biotechnol.</source> <volume>37</volume> (<issue>8</issue>), <fpage>907</fpage>&#x2013;<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id>
<pub-id pub-id-type="pmid">31375807</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovaka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zimin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Pertea</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Razaghi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Pertea</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Transcriptome assembly from long-read RNA-seq alignments with StringTie2</article-title>. <source>Genome Biol.</source> <volume>20</volume> (<issue>1</issue>), <fpage>278</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-019-1910-1</pub-id>
<pub-id pub-id-type="pmid">31842956</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamb</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Holton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>O&#x27;Connor</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Giannoudis</surname>
<given-names>P. V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Avascular necrosis of the hip</article-title>. <source>BMJ Clin. Res. ed</source> <volume>365</volume>, <fpage>l2178</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.l2178</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawlor</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Vince</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Gasdermin and MLKL necrotic cell death effectors: signaling and diseases</article-title>. <source>Immunity</source> <volume>12</volume> (<issue>3</issue>), <fpage>429</fpage>&#x2013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2024.02.011</pub-id>
<pub-id pub-id-type="pmid">38479360</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head</article-title>. <source>Stem Cell Res. Ther.</source> <volume>11</volume> (<issue>1</issue>), <fpage>480</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-020-01991-2</pub-id>
<pub-id pub-id-type="pmid">33176873</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2020b</year>). <article-title>The protective effects of microRNA-26a in steroid-induced osteonecrosis of the femoral head by repressing EZH2</article-title>. <source>Cell Cycle</source> <volume>19</volume> (<issue>5</issue>), <fpage>551</fpage>&#x2013;<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2020.1717043</pub-id>
<pub-id pub-id-type="pmid">32054404</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes</article-title>. <source>Biomaterials</source> <volume>284</volume>, <fpage>121529</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121529</pub-id>
<pub-id pub-id-type="pmid">35447403</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Exogenous melatonin ameliorates steroid-induced osteonecrosis of the femoral head by modulating ferroptosis through GDF15-mediated signaling</article-title>. <source>Stem Cell Res. Ther.</source> <volume>14</volume> (<issue>1</issue>), <fpage>171</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-023-03371-y</pub-id>
<pub-id pub-id-type="pmid">37400902</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>BMSC-derived exosomes carrying microRNA-122-5p promote proliferation of osteoblasts in osteonecrosis of the femoral head</article-title>. <source>Clin. Sci. (Lond)</source> <volume>133</volume> (<issue>18</issue>), <fpage>1955</fpage>&#x2013;<lpage>1975</lpage>. <pub-id pub-id-type="doi">10.1042/cs20181064</pub-id>
<pub-id pub-id-type="pmid">31387936</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Synthetic biology-based bacterial extracellular vesicles displaying BMP-2 and CXCR4 to ameliorate osteoporosis</article-title>. <source>J. Extracell. Vesicles</source> <volume>13</volume> (<issue>4</issue>), <fpage>e12429</fpage>. <pub-id pub-id-type="doi">10.1002/jev2.12429</pub-id>
<pub-id pub-id-type="pmid">38576241</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia-reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps</article-title>. <source>Biomaterials</source> <volume>284</volume>, <fpage>121486</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121486</pub-id>
<pub-id pub-id-type="pmid">35447404</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKinley</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Longaker</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Naik</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Emerging frontiers in regenerative medicine</article-title>. <source>Science</source> <volume>380</volume> (<issue>6647</issue>), <fpage>796</fpage>&#x2013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1126/science.add6492</pub-id>
<pub-id pub-id-type="pmid">37228215</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<collab>Microsurgery Department of the Orthopedics Branch of the Chinese Medical Doctor A, Group from the O, Bone Defect Branch of the Chinese Association of R, Reconstructive S, Microsurgery, Reconstructive Surgery Group of the Orthopedics Branch of the Chinese Medical AGroup from the Osteonecrosis and Bone Defect Branch of the Chinese Association of Reparative and Reconstructive SurgeryMicrosurgery and Reconstructive Surgery Group of the Orthopedics Branch of the Chinese Medical Association</collab> (<year>2017</year>). <article-title>Chinese guideline for the diagnosis and treatment of osteonecrosis of the femoral head in adults</article-title>. <source>Orthop. Surg.</source> <volume>9</volume> (<issue>1</issue>), <fpage>3</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/os.12302</pub-id>
<pub-id pub-id-type="pmid">28371498</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Migliorini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Maffulli</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baroncini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eschweiler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tingart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Betsch</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Failure and progression to total hip arthroplasty among the treatments for femoral head osteonecrosis: a Bayesian network meta-analysis</article-title>. <source>Br. Med. Bull.</source> <volume>138</volume> (<issue>1</issue>), <fpage>112</fpage>&#x2013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1093/bmb/ldab006</pub-id>
<pub-id pub-id-type="pmid">34009284</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miladi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Villain</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mebtouche</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Begue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Auregan</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Interest of short implants in hip arthroplasty for osteonecrosis of the femoral head: comparative study &#x201c;uncemented short&#x201d; vs &#x201c;cemented conventional&#x201d; femoral stems</article-title>. <source>Int. Orthop.</source> <volume>42</volume> (<issue>7</issue>), <fpage>1669</fpage>&#x2013;<lpage>1674</lpage>. <pub-id pub-id-type="doi">10.1007/s00264-018-3981-0</pub-id>
<pub-id pub-id-type="pmid">29761221</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mimura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Furuta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study</article-title>. <source>RMD Open</source> <volume>9</volume> (<issue>1</issue>), <fpage>e002787</fpage>. <pub-id pub-id-type="doi">10.1136/rmdopen-2022-002787</pub-id>
<pub-id pub-id-type="pmid">36849207</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu)</article-title>. <source>Stem Cell Res. Ther.</source> <volume>12</volume> (<issue>1</issue>), <fpage>331</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-021-02390-x</pub-id>
<pub-id pub-id-type="pmid">34099038</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padhye</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dalla-Pozza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Munns</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL)</article-title>. <source>Cancer Med.</source> <volume>5</volume> (<issue>5</issue>), <fpage>960</fpage>&#x2013;<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.645</pub-id>
<pub-id pub-id-type="pmid">26792372</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parate</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kadir</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Celik</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>J. H. P.</given-names>
</name>
<name>
<surname>Franco-Obreg&#xf3;n</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pulsed electromagnetic fields potentiate the paracrine function of mesenchymal stem cells for cartilage regeneration</article-title>. <source>Stem Cell Res. Ther.</source> <volume>11</volume> (<issue>1</issue>), <fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-020-1566-5</pub-id>
<pub-id pub-id-type="pmid">32014064</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadile</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bernasconi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maffulli</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis</article-title>. <source>Br. Med. Bull.</source> <volume>118</volume> (<issue>1</issue>), <fpage>33</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1093/bmb/ldw010</pub-id>
<pub-id pub-id-type="pmid">27298230</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Inhibition of sympathetic tone via hypothalamic descending pathway propagates glucocorticoid-induced endothelial impairment and osteonecrosis of the femoral head</article-title>. <source>Bone Res.</source> <volume>12</volume> (<issue>1</issue>), <fpage>64</fpage>. <pub-id pub-id-type="doi">10.1038/s41413-024-00371-3</pub-id>
<pub-id pub-id-type="pmid">39516484</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Feasibility of lentiviral-mediated sodium iodide symporter gene delivery for the efficient monitoring of bone marrow-derived mesenchymal stem cell transplantation and survival</article-title>. <source>Int. J. Mol. Med.</source> <volume>34</volume> (<issue>6</issue>), <fpage>1547</fpage>&#x2013;<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2014.1970</pub-id>
<pub-id pub-id-type="pmid">25319483</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonnier</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kolomytkin</surname>
<given-names>O. V.</given-names>
</name>
<name>
<surname>Marino</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Resting potential of excitable neuroblastoma cells in weak magnetic fields</article-title>. <source>Cell Mol. Life Sci.</source> <volume>57</volume> (<issue>3</issue>), <fpage>514</fpage>&#x2013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1007/PL00000712</pub-id>
<pub-id pub-id-type="pmid">10823251</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rui</surname>
<given-names>B. Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C. Q.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway</article-title>. <source>Theranostics</source> <volume>7</volume> (<issue>3</issue>), <fpage>733</fpage>&#x2013;<lpage>750</lpage>. <pub-id pub-id-type="doi">10.7150/thno.17450</pub-id>
<pub-id pub-id-type="pmid">28255363</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thakur</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-W.</given-names>
</name>
<name>
<surname>Motallebnejad</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics</article-title>. <source>Protein Cell</source> <volume>13</volume> (<issue>9</issue>), <fpage>631</fpage>&#x2013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1007/s13238-021-00863-6</pub-id>
<pub-id pub-id-type="pmid">34374936</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>von Meyenn</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hewitt</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weightman</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions</article-title>. <source>Nat. Commun.</source> <volume>11</volume> (<issue>1</issue>), <fpage>1528</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-15271-3</pub-id>
<pub-id pub-id-type="pmid">32251294</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Small extracellular vesicles derived from hypoxic preconditioned dental pulp stem cells ameliorate inflammatory osteolysis by modulating macrophage polarization and osteoclastogenesis</article-title>. <source>Bioact. Mater</source> <volume>22</volume>, <fpage>326</fpage>&#x2013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2022.10.001</pub-id>
<pub-id pub-id-type="pmid">36311048</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trentini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>D&#x27;Amora</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Ronca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lovatti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Calvo-Guirado</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Licastro</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Bone regeneration revolution: pulsed electromagnetic field modulates macrophage-derived exosomes to attenuate osteoclastogenesis</article-title>. <source>Int. J. Nanomedicine</source> <volume>19</volume>, <fpage>8695</fpage>&#x2013;<lpage>8707</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S470901</pub-id>
<pub-id pub-id-type="pmid">39205866</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Pulsed electromagnetic fields attenuate glucocorticoid-induced bone loss by targeting senescent LepR&#x2b; bone marrow mesenchymal stromal cells</article-title>. <source>Biomater. Adv.</source> <volume>133</volume>, <fpage>112635</fpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2021.112635</pub-id>
<pub-id pub-id-type="pmid">35527160</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Harnessing extracellular vesicles from Lactobacillus reuteri and Lactobacillus paracasei for synergistic osteoporosis therapy</article-title>. <source>Compos. Part B Eng.</source> <volume>297</volume>, <fpage>112255</fpage>. <pub-id pub-id-type="doi">10.1016/j.compositesb.2025.112255</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>C. J. K.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>J. L. Y.</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>C. H. H.</given-names>
</name>
<name>
<surname>Loo</surname>
<given-names>L. S. W.</given-names>
</name>
<name>
<surname>Kukumberg</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Brief exposure to directionally-specific pulsed electromagnetic fields stimulates extracellular vesicle release and is antagonized by streptomycin: a potential regenerative medicine and food industry paradigm</article-title>. <source>Biomaterials</source> <volume>287</volume>, <fpage>121658</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121658</pub-id>
<pub-id pub-id-type="pmid">35841726</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>W.-N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis</article-title>. <source>Biomaterials</source> <volume>206</volume>, <fpage>87</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.03.022</pub-id>
<pub-id pub-id-type="pmid">30927715</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Exosomes derived from bone marrow mesenchymal stem cell preconditioned by low-intensity pulsed ultrasound stimulation promote bone-tendon interface fibrocartilage regeneration and ameliorate rotator cuff fatty infiltration</article-title>. <source>J. Orthop. Transl.</source> <volume>48</volume>, <fpage>89</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2024.07.009</pub-id>
<pub-id pub-id-type="pmid">39189009</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration</article-title>. <source>Biomaterials</source> <volume>269</volume>, <fpage>120539</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120539</pub-id>
<pub-id pub-id-type="pmid">33243424</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>X. N.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The effect of different frequencies of pulsed electromagnetic fields on cartilage repair of adipose mesenchymal stem cell-derived exosomes in osteoarthritis</article-title>. <source>Cartilage</source> <volume>13</volume> (<issue>4</issue>), <fpage>200</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1177/19476035221137726</pub-id>
<pub-id pub-id-type="pmid">36377077</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>High-specificity protection against radiation-induced bone loss by a pulsed electromagnetic field</article-title>. <source>Sci. Adv.</source> <volume>8</volume> (<issue>34</issue>), <fpage>eabq0222</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abq0222</pub-id>
<pub-id pub-id-type="pmid">36001662</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Pulsed electromagnetic field improves subchondral bone microstructure in knee osteoarthritis rats through a Wnt/&#x3b2;-catenin signaling-associated mechanism</article-title>. <source>Bioelectromagnetics</source> <volume>39</volume> (<issue>2</issue>), <fpage>89</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1002/bem.22106</pub-id>
<pub-id pub-id-type="pmid">29251361</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head</article-title>. <source>Clin. Transl. Med.</source> <volume>11</volume> (<issue>6</issue>), <fpage>e447</fpage>. <pub-id pub-id-type="doi">10.1002/ctm2.447</pub-id>
<pub-id pub-id-type="pmid">34185425</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ofengeim</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>20</volume> (<issue>1</issue>), <fpage>19</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/s41583-018-0093-1</pub-id>
<pub-id pub-id-type="pmid">30467385</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)</article-title>. <source>J. Orthop. Transl.</source> <volume>21</volume>, <fpage>100</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2019.12.004</pub-id>
<pub-id pub-id-type="pmid">32309135</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Effects of puerarin-loaded tetrahedral framework nucleic acids on osteonecrosis of the femoral head</article-title>. <source>Small Weinheim Der Bergstrasse, Ger.</source> <volume>19</volume> (<issue>41</issue>), <fpage>e2302326</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202302326</pub-id>
<pub-id pub-id-type="pmid">37317020</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Organoids and organoid extracellular vesicles-based disease treatment strategies</article-title>. <source>J. Nanobiotechnology</source> <volume>22</volume> (<issue>1</issue>), <fpage>679</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-024-02917-3</pub-id>
<pub-id pub-id-type="pmid">39506799</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cigarette smoke promotes oral leukoplakia via regulating glutamine metabolism and M2 polarization of macrophage</article-title>. <source>Int. J. Oral Sci.</source> <volume>13</volume> (<issue>1</issue>), <fpage>25</fpage>. <pub-id pub-id-type="doi">10.1038/s41368-021-00128-2</pub-id>
<pub-id pub-id-type="pmid">34373444</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Exosomes derived from human CD34(&#x2b;) stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis</article-title>. <source>Stem Cell Res. Ther.</source> <volume>10</volume> (<issue>1</issue>), <fpage>321</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-019-1426-3</pub-id>
<pub-id pub-id-type="pmid">31730486</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>